Current Neuro-Oncology
Volume
26 Number 7
15 April 2024
Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 7, 15 April
Fehrenbach MK, Wilhelmy F, Wende T, Güresir E, Kasper
J.
Perioperative psychological distress
in patients with intracranial tumors; a single center study.
J
Neurooncol. 2024 Apr 2. doi:
10.1007/s11060-024-04657-8. PMID:
38563854. Observational study˰
ˍ
Xiang Y, Chen Y, Xu Z, Zhou S, Qin Z, Chen L, Xiao D, Liu
S.
Real-world cost-effectiveness
analysis: Tumor Treating Fields for newly diagnosed glioblastoma
in China.
J
Neurooncol. 2024 Apr 2. doi:
10.1007/s11060-024-04662-x. PMID:
38563851. Observational study˰
ˍ
Mirzayeva L, Uçar M, Kaymaz AM, Temel E.
Intraoperative
magnetic resonance imaging in glioma surgery: a single-center
experience.
J
Neurooncol. 2024 Apr 3. doi:
10.1007/s11060-024-04660-z. PMID:
38568377. Observational study. ˍ
Ricklefs FL, Wollmann K, Salviano-Silva A, Drexler R, Maire CL,
Kaul MG, Reimer R, Schüller U, Heinemann S, Kolbe K, Mummert
T, Glatzel M, Peine S, Gempt J, Westphal M, Dührsen L,
Lamszus K.
Circulating extracellular
vesicles as biomarker for diagnosis, prognosis and monitoring in
glioblastoma patients.
Neuro
Oncol. 2024 Apr 3:noae068. doi:
10.1093/neuonc/noae068. PMID:
38567448. Observational study˰
ˍ
Spoor JKH, Donders-Kamphuis M, Veenstra WS, van Dijk SA, Dirven
CMF, Sillevis Smitt PAE, van den Bent MJ, Leenstra S, Satoer
DD.
Cognition and health-related
quality of life in long-term survivors of high-grade glioma: an
interactive perspective from patient and caregiver.
Acta
Neurochir (Wien). 2024 Apr 3;166(1):166. doi:
10.1007/s00701-024-06037-7. PMID:
38565800. Observational study. ˍ
Liu J, Hu S, Jiang H, Cui Y.
Case
report: Temozolomide induced hypermutation indicates an
unfavorable response to immunotherapy in patient with
gliomas.
Front
Immunol. 2024 Apr 4;15:1369972. doi:
10.3389/fimmu.2024.1369972. PMID:
38690285. Case report. ˍ
Obrecht-Sturm D, Schömig L, Mynarek M, Bison B, Schwarz R,
Pietsch T, Pfister SM, Sill M, Sturm D, Sahm F, Kortmann RD,
Gerber NU, von Bueren AO, Fleischhack G, Schüller U,
Nussbaumer G, Benesch M, Rutkowski S.
Treatment
response as surrogate to predict risk for disease progression in
pediatric medulloblastoma with persistent MRI lesions after
first-line treatment.
Neuro
Oncol. 2024 Apr 5:noae071. doi:
10.1093/neuonc/noae071. PMID:
38578306. Observational study˰
ˍ
Zugman M, Haslam A, Prasad V.
INDIGO:
Example of inappropriate crossover and why PFS cannot be the
primary outcome in gliomas.
J
Cancer Policy. 2024 Apr 6;40:100476. doi:
10.1016/j.jcpo.2024.100476. PMID:
38588795. Comment˰ ˍ
RELATED
ARTICLE
Mellinghoff IK, van den Bent MJ, Blumenthal DT, Touat M, Peters
KB, Clarke J, Mendez J, Yust-Katz S, Welsh L, Mason WP, Ducray F,
Umemura Y, Nabors B, Holdhoff M, Hottinger AF, Arakawa Y,
Sepulveda JM, Wick W, Soffietti R, Perry JR, Giglio P, de la
Fuente M, Maher EA, Schoenfeld S, Zhao D, Pandya SS, Steelman L,
Hassan I, Wen PY, Cloughesy TF.
Vorasidenib
in IDH1- or IDH2-Mutant Low-Grade Glioma.
N
Engl J Med.
2023 Jun 4. doi:
10.1056/NEJMoa2304194. PMID:
37272516. Interventional study. ˍ
Gregory TA, Knight SR, Aaroe AE, Highsmith KN, Janatpour ZC,
O'Brien BJ, Majd NK, Loghin ME, Patel CB, Weathers SP, Puduvalli
VK, Kamiya-Matsuoka C.
Accelerated
tumor progression after COVID-19 infection in patients with
glioblastoma: A retrospective case-control study.
Neurooncol
Pract. 2024 Apr 8;11(4):475-483. doi:
10.1093/nop/npae029. PMID:
39006516.
Observational
study˰ ˍ
*Geurts M, Preusser M.
Locoregional
delivery of CAR-T cells - breaking the spell in
glioblastoma?
Neuro
Oncol. 2024 Apr 9:noae063. doi:
10.1093/neuonc/noae063. PMID:
38592708. Editorial. ˍ
RELATER
ARTICLES
-Choi BD, Gerstner ER, Frigault
MJ, Leick MB, Mount CW, Balaj L, Nikiforow S, Carter BS, Curry WT,
Gallagher K, Maus MV.
Intraventricular
CARv3-TEAM-E T Cells in Recurrent Glioblastoma.
N
Engl J Med.
2024 Mar 13;390(14):1290-1298. doi:
10.1056/NEJMoa2314390. PMID:
38477966. Interventional study. ˍ
-Bagley SJ, Logun M, Fraietta
JA, Wang X, Desai AS, Bagley LJ, Nabavizadeh A, Jarocha D, Martins
R, Maloney E, Lledo L, Stein C, Marshall A, Leskowitz R, Jadlowsky
JK, Christensen S, Oner BS, Plesa G, Brennan A, Gonzalez V, Chen
F, Sun Y, Gladney W, Barrett D, Nasrallah MP, Hwang WT, Ming GL,
Song H, Siegel DL, June CH, Hexner EO, Binder ZA, O'Rourke
DM.
Intrathecal
bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent
glioblastoma: phase 1 trial interim results.
Nat
Med. 2024
Mar 13. doi:
10.1038/s41591-024-02893-z. PMID:
38480922. Interventional study˰ ˍ
-Brown CE, Hibbard JC, Alizadeh
D, Blanchard MS, Natri HM, Wang D, Ostberg JR, Aguilar B, Wagner
JR, Paul JA, Starr R, Wong RA, Chen W, Shulkin N, Aftabizadeh M,
Filippov A, Chaudhry A, Ressler JA, Kilpatrick J, Myers-McNamara
P, Chen M, Wang LD, Rockne RC, Georges J, Portnow J, Barish ME,
D'Apuzzo M, Banovich NE, Forman SJ, Badie B.
Locoregional
delivery of IL-13Rα2-targeting CAR-T cells in recurrent
high-grade glioma: a phase 1 trial.
Nat
Med. 2024
Mar 7. doi:
10.1038/s41591-024-02875-1. PMID:
38454126. Interventional study. ˍ
Kawaguchi
Y, Watanabe Y, Miyakita Y, Ohno M, Ogawa C, Takahashi M,
Yanagisawa S, Mukai T, Igaki H, Sugino H, Yoshida A, Narita Y.
Successful
treatment of pediatric patients with high-grade gliomas featuring
leptomeningeal metastases by targeting BRAF V600E mutations with
dabrafenib plus trametinib: two illustrative cases.
Int
Cancer Conf J.
2024 Apr 10;13(3):256-262. doi:
10.1007/s13691-024-00674-6. PMID:
38962052. Case report˰ ˍ
Tohidinezhad F, Zegers CML, Vaassen F, Dijkstra J, Anten M, Van
Elmpt W, De Ruysscher D, Dekker A, Eekers DBP, Traverso
A.
Predicting the risk of
neurocognitive decline after brain irradiation in adult patients
with a primary brain tumor.
Neuro
Oncol. 2024 Apr 10:noae035. doi:
10.1093/neuonc/noae035. PMID:
38595122. Observational study. ˍ
Gong J, Mita AC, Wei Z, Cheng HH, Mitchell EP, Wright JJ, Ivy SP,
Wang V, Gray RC, McShane LM, Rubinstein LV, Patton DR, Williams
PM, Hamilton SR, Tricoli JV, Conley BA, Arteaga CL, Harris LN,
O'Dwyer PJ, Chen AP, Flaherty KT.
Phase
II Study of Erdafitinib in Patients With Tumors With Fibroblast
Growth Factor Receptor Mutations or Fusions: Results From the
NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2.
JCO
Precis Oncol. 2024 Apr 11;8:e2300407. doi:
10.1200/PO.23.00407. PMID:
38603650. Interventional study˰
ˍ
Lunde CE, Dudek MR, Talbert CA, Sieberg CB, Silva KE, Papadelis C,
Ullrich NJ, Manley PE, Moulton EA.
The
long-term impact of cerebellar tumor resection on executive
functioning, anxiety, and fear of pain: A mixed methodology pilot
study.
Appl
Neuropsychol Child. 2024 Apr 11:1-11. doi:
10.1080/21622965.2024.2337208. PMID:
38604218. Observational study˰
ˍ
Cicutti SE, Del Río RJ, Cáceres A, Gonzalez Ramos
JD.
Pediatric hemispheric cerebellar
low-grade gliomas: clinical approach, diagnosis, and management
challenges-experience at a tertiary care children's
hospital.
Childs
Nerv Syst. 2024 Apr 12. doi:
10.1007/s00381-024-06394-9. PMID:
38607550. Observational study˰
ˍ
Bocanegra-Becerra JE, Novoa-Ramírez LF, Latorre-Zúñiga
AJ, Tacas-Gil N, Rojas-Apaza R.
Primary
intracranial peripheral primitive neuroectodermal tumor: lessons
from an exceptionally rare neoplasm. Illustrative case.
J
Neurosurg Case Lessons. 2024 Apr 15;7(16):CASE24133.
doi:
10.3171/CASE24133. PMID:
38621307. Case report. ˍ
*Ezaki T, Tanaka T, Tamura R, Ohara K, Yamamoto Y, Takei J,
Morimoto Y, Imai R, Kuranai Y, Akasaki Y, Toda M, Murayama Y,
Miyake K, Sasaki H.
Status of
alternative angiogenic pathways in glioblastoma resected under and
after bevacizumab treatment.
Brain
Tumor Pathol. 2024 Apr 15. doi:
10.1007/s10014-024-00481-0. PMID:
38619734. Observational study; Laboratory investigation. ˍ
Huang
R, Lu X, Sun X, Wu H.
Prognostic
significance of alterations in fibrinogen level and
fibrinogen-to-lymphocyte ratio after radiotherapy on survival
outcomes in glioblastoma.
Transl
Cancer Res.
2024 Apr 15;13(4):1887-1903. doi:
10.21037/tcr-23-2271. PMID:
38737673. Observational study. ˍ
*Shelton WJ, Mathews AP, Aljiboori K, Nix JS, Gokden M, Rodriguez
A.
A rare case of atypical intradural
extramedullary glioblastoma diagnosed utilizing next-generation
sequencing and methylation profiling: illustrative case.
J
Neurosurg Case Lessons. 2024 Apr 15;7(16):CASE24103.
doi:
10.3171/CASE24103. PMID:
38621302. Case report. ˍ